CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation be better for HPV throat cancer? new trial aims to find out
Disease control Not yet recruitingThis study tests whether giving a lower dose of radiation to the neck lymph nodes that are not directly affected by cancer can still effectively treat HPV-related throat cancer while causing fewer side effects. About 100 adults with early-stage HPV-positive throat cancer will rec…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
New hope for head and neck cancer patients who Can't take standard chemo
Disease control Not yet recruitingThis study tests two different treatments for people with advanced head and neck cancer who cannot receive the standard drug cisplatin. Participants will get radiation therapy along with either the targeted drug cetuximab or a combination of two chemotherapy drugs, carboplatin an…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:55 UTC